TY  - RPRT
TI  - Targeted Nanoparticle Delivery CRISPR/Cas9: overcoming biological barriers, enhancing stability, and improving therapeutic precision.
AU  - Sriwidodo Sriwidodo
AU  - Cecep Suhandi
AU  - Salsa Sagitasa
AU  - Belva Annora Alfita Davinali
AU  - Iman Permana Maksum
AU  - Sabreena Safuan
PY  - 2026
DO  - 10.1016/j.ijpx.2026.100643
UR  - https://pubmed.ncbi.nlm.nih.gov/42699102/
ID  - 42699102
ER  -